Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Multicentre trial of naproxen and phenylbutazone in acute gout.

1977; BMJ; Volume: 36; Issue: 1 Linguagem: Inglês

10.1136/ard.36.1.80

ISSN

1468-2060

Autores

R. A. Sturge, J. T. Scott, E B Hamilton, S P Liyanage, A. St. J. Dixon, J. N. P. Davies, C. Engler,

Tópico(s)

Alcohol Consumption and Health Effects

Resumo

Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.

Referência(s)